'Exciting breakthrough': COVID-19 drug trial to take place in Edmonton
Trials for a Canadian-developed COVID-19 treatment are set to begin at the University of Alberta.
The study will evaluate the safety and efficacy of the drug Apabetalone as a potential oral medication to help prevent severe infection from COVID-19.
“It’s a pretty exciting breakthrough,” Donald McCaffrey, the president and CEO of Resverlogix, said.
The clinical program will test epigenetics on COVID-19 patients, including those who were sick with a variant strain.
“The genetics is the hardware, the epigenetics is the software. The science of learning to turn on or off various genes,” McCaffrey explained.
The drug has been in development for more than 20 years and when COVID-19 emerged, a group of universities began studying drugs already in production that could be repurposed to help fight COVID-19. Apabetalone ended up being “number two on the list,” according to McCaffrey.
“We do have a huge lead on the world in knowledge on this (protein) and how to remove it.”
The drug is an oral pill taken once in the morning and once at night. A total of 100 patients are expected to be enrolled over the coming week to take part in the trial at various sites in Canada and Brazil.
“By removing the bromodomain (BD2) and shutting down the ACE2 receptors, you’re greatly inhibiting the virus’s ability to reproduce,” McCaffrey shared.
'WE DO NOT CHANGE THE HUMAN DNA'
The average COVID-19 hospital stay right now is 11.9 days, McCaffrey told CTV News Edmonton. That stay increases up to 23 days if the patient has cardiovascular issues. He said the cost can range from $26,000 to $52,000 per patient receiving care.
“The goal is to show that we can remove the long hospital stays.”
McCaffrey said because of Apabetalone’s unique epigenetic mechanism, it has the ability to stop disease progression by regulating the “expression” of disease and inflammation-causing genes.
“We do not change the human DNA; it remains identical,” he said. “But, we do turn the genes on or off, and that has a huge therapeutic benefit for our patients.”
In addition to reducing the duration of the disease, the hope is that the drug will also potentially be able to protect those infected from the long-term effects of long-COVID.
'IT WILL BE EFFECTIVE'
Apabetalone would cost about $7 per pill and should be taken for two to three weeks, McCaffrey said.
If the trials are successful, the team's next step would be to apply for an emergency management application in Canada in June, and then in the U.S. about six months later, McCaffrey explained.
“The vaccine is the most important thing at the moment,” Dr. Noel Gibney, professor emeritus, critical care medicine at the U of A, added. “But, we know that even with vaccination, people with critically poor immune systems are still at risk. So, it really is important that we have other therapies.”
With years of data backing the science, efficacy and safety of the drug, McCaffrey is confident it could help “manage the real problem,” which he says is the “bottleneck” in hospitals.
“No matter what Greek alphabet we get hit with next, it will be effective against all future variants.”
With files from CTV News Edmonton’s Carlyle Fiset
CTVNews.ca Top Stories
Which Canadian cities have the highest and lowest grocery prices?
Where you live plays a big factor in what you pay at the grocery store. And while it's no secret the same item may have a different price depending on the store, city or province, we wanted to see just how big the differences are, and why.
'State or state-sponsored actor' believed to be behind B.C. government hacks
The head of British Columbia’s civil service has revealed that a “state or state-sponsored actor” is behind multiple cyber-security incidents against provincial government networks.
Swarm of 20,000 bees gather around woman’s car west of Toronto
A swarm of roughly 20,000 bees gathered around a woman’s car in the parking lot of Burlington Centre.
Mother assaulted by stranger while breastfeeding baby in her car: Vancouver police
A person was arrested in East Vancouver Thursday after allegedly entering a car while a mother was breastfeeding her four-month-old boy.
More than half the Canadians once detained in Syrian camps for suspected ISIS family members have returned home
A total of 29 Canadians have been freed from detention camps in northeast Syria and brought back to Canada since human rights advocates began lobbying for their release years ago.
Rare severe solar storm Friday could bring spectacular aurora light show across Canada
A rare and severe solar storm is expected to bring spectacular displays of the northern lights, also known as aurora borealis, across much of Canada and parts of the United States on Friday night.
Canada abstains from Palestinian UN membership vote but supports two-state solution
Canada was one of 25 countries that abstained from a United Nations vote on Palestinian membership that passed with overwhelming support on Friday.
Amish youth experience a rite of passage called Rumspringa. It’s not what you might think
The idea of “Rumspringa” has a specific spot in the American imagination. A rite of passage for young people in some Amish communities, Rumspringa is seen by most outsiders as a wild time away from strict Amish rules, when teenagers can experiment with the modern vices of the world.
Djokovic needs medical attention after getting knocked on the head by a water bottle at Italian Open
Novak Djokovic needed medical attention after apparently getting knocked on the head by a water bottle after a win at the Italian Open on Friday.